Home » Senate Healthcare Bill Includes User Fees But Scraps Drug Price Negotiation
Senate Healthcare Bill Includes User Fees But Scraps Drug Price Negotiation
November 20, 2009
The Senate’s $849 billion healthcare overhaul legislation, like the House version, gives biologics innovators 12 years of exclusivity and requires
a 50 percent discount on negotiated prices for brand drugs in Medicare formularies when beneficiaries fall into a coverage gap, but unlike the House bill,
it would charge brand-drug makers $2.3 billion in annual fees.